|
|
Volumn 183, Issue 5, 2009, Pages 2891-
|
|
Comment on "direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2"
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANNEXIN;
CRE RECOMBINASE;
CREER T2 PROTEIN;
TAMOXIFEN;
UNCLASSIFIED DRUG;
CREER TC PROTEIN;
PROTEIN PATCHED;
ESTROGEN RECEPTOR;
GTROSA26 PROTEIN, MOUSE;
INTEGRASE;
PROTEIN;
APOPTOSIS;
B LYMPHOCYTE;
BLOOD TOXICITY;
BONE MARROW;
CELL COUNT;
CELL PROLIFERATION;
ENZYME ACTIVATION;
GENE INACTIVATION;
GENETIC RECOMBINATION;
HUMAN;
LETTER;
NONHUMAN;
PRIORITY JOURNAL;
SPLEEN;
T LYMPHOCYTE;
THYMUS;
THYMUS ATROPHY;
TISSUE STRUCTURE;
ALLELE;
COHORT ANALYSIS;
GENE LOCUS;
GENE SEGREGATION;
HEMATOLOGIC DISEASE;
MOUSE STRAIN;
PHENOTYPE;
RESTING SPORE;
ANEMIA;
ANIMAL;
C57BL MOUSE;
ENZYMOLOGY;
GENE TARGETING;
GENETICS;
HEMATOPOIETIC STEM CELL;
IMMUNOLOGY;
MALE;
METABOLISM;
MOUSE;
NOTE;
TRANSCRIPTION INITIATION;
TRANSGENIC MOUSE;
ANEMIA;
ANIMALS;
GENE KNOCK-IN TECHNIQUES;
HEMATOPOIETIC STEM CELLS;
INTEGRASES;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, TRANSGENIC;
PROTEINS;
RECEPTORS, ESTROGEN;
RECOMBINATION, GENETIC;
TAMOXIFEN;
TRANSCRIPTIONAL ACTIVATION;
|
|
EID: 70349246523
PISSN: 00221767
EISSN: 15506606
Source Type: Journal
DOI: 10.4049/jimmunol.0990063 Document Type: Letter |
|
Times cited : (4)
|
|
References (3)
|
